Nikolaos Takmopoulos

@Ajovista, Llc

Latest period2024 - Q3

Reported2mo 7d ago

Managed Assets$23.402M

Total holdings112

Assets growth rate-32.52%

Assets growth rate (2-Q avg)-19.29%

Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Ajovista, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 112 positions.

Assets under management

The assets under management (AUM) of Ajovista, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 23.402M in assets, with a quarterly growth rate of -32.52% and a 2-quarter average growth rate of -19.29%. The portfolio is managed by Nikolaos Takmopoulos, and others.

Portfolio holdings

Current New Position Increased Decreased Exited

Investment	Portfolio %	Reported Value	Recent Activity
EGRXEagle Pharmaceuticals Inc Recent Activity Increased 402.48%	0.9%	$210,514 56,438 shares@ $3.74 avg price	Increased 402.48%
REALThe Realreal Inc Recent Activity Increased 215.09%	0.58%	$135,535 43,164 shares@ $3.15 avg price	Increased 215.09%
HNSTHonest Co Inc Recent Activity Increased 41.49%	0.57%	$131,115 36,727 shares@ $3.57 avg price	Increased 41.49%
UISUnisys Corp Recent Activity Increased 29.33%	0.34%	$77,577 13,658 shares@ $5.68 avg price	Increased 29.33%
SVRASavara Inc Recent Activity Increased 19.48%	0.29%	$66,191 15,611 shares@ $4.25 avg price	Increased 19.48%
CDXCChromadex Corp Recent Activity Increased 73.58%	0.28%	$64,065 17,552 shares@ $3.66 avg price	Increased 73.58%
ORGOOrganogenesis Hldgs Inc Recent Activity Increased 39.04%	0.27%	$61,684 21,568 shares@ $2.86 avg price	Increased 39.04%
HRTXHeron Therapeutics Inc Recent Activity Increased 14.07%	0.2%	$44,759 22,492 shares@ $1.99 avg price	Increased 14.07%